OPIANT PHARMACEUTICALS, INC. Business Operations Contracts & Agreements
8 Contracts & Agreements
- Development Agreements (4 contracts)
- Services Agreements (3)
- Supply Agreements (1)
- Master Services Agreement dated October 26, 2020 between the Company and AptarGroup, Inc (Filed With SEC on October 29, 2020)
- Master Services Agreement dated July 1, 2020 and Project Scope Agreement dated July 22, 2020 between the Company and Summit Biosciences, Inc (Filed With SEC on July 28, 2020)
- Contract between the Company and Biomedical Advanced Research and Development Authority dated September 19, 2018 (Filed With SEC on December 4, 2018)
- Contract between the Company and Biomedical Advanced Research and Development Authority dated September 19, 2018 (Filed With SEC on September 20, 2018)
- Development and Manufacturing Agreement between the Company and Aesica Queensborough Limited dated September 7, 2018 (Filed With SEC on September 10, 2018)
- Agreement for Reimbursement of Capital Expenditures and Service Fees between the Company and Aesica Queensborough Limited dated September 7, 2018 (Filed With SEC on September 10, 2018)
- Supply Agreement, dated as of June 22, 2017, by and between the Company and Aegis Therapeutics, LLC (Filed With SEC on October 13, 2017)
- Research and Development Agreement, dated as of July 14, 2017, by and between the Company and Renaissance Lakewood, LLC (Filed With SEC on October 13, 2017)
